To determine the role of glucagon and glucagon-related peptides in type 2 diabetes, and whether hyperproglucagonaemia exists independently of obesity, MASLD and type 2 diabetes, we analysed data from the UK Biobank including data from nearly 500,000 individuals. This evidence concerns the gene GCG and type 2 diabetes mellitus.